Vertebral Column Articles & Analysis
7 news found
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS) and improved key clinically relevant endpoints in patients with various types of metastatic disease burden and risk, compared to ADT with docetaxel alone Favorable safety profile of darolutamide plus ADT in combination ...
ByBayer AG
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, today announced that on November 17, 2021, its board of directors appointed John Collins as a replacement independent director to a vacancy on the Company´s board of directors and audit committee. Timothy Damadian, president and CEO of FONAR, said, “Our primary source of income and growth is attributable to FONAR’s ...
Total MRI scan volume at the HMCA-managed sites increased 11.6 % to 48,469 scans for the quarter ending September 30, 2021 versus the same quarter one year earlier. This is highest quarterly total in the Company’s history. Diluted Net Income per Common Share increased 53% to $0.55 for the quarter ended September 30, 2021 versus the same quarter one year earlier. Total Revenues-Net ...
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, announced today that it has acquired a Stand-Up MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C. Tim Damadian, president and CEO of FONAR Corporation, said, ...
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, will ring the Nasdaq Stock Market Closing Bell on March 9, 2021. Nasdaq and FONAR selected this day as it is 50 years since the discovery of MRI by Raymond V. Damadian, M.D., FONAR’s founder and chairman, was published in the widely-read, peer-reviewed scientific journal Science on March 19, 1971.* To access the live ...
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, reported today that upon the opening of U.S. markets on June 29, 2020, FONAR will, as part of the annual reconstitution of the Russell Indexes, be joining the broad-market Russell 3000 Index and the Russell 2000 Index. The Russell 3000 Index is a market-capitalization-weighted equity index that tracks the performance of the 3,000 ...
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, celebrated a special anniversary on September 17, 2019: It was 50 years ago that Raymond V. Damadian, M.D., founder and chairman of FONAR Corporation, first thought about developing a device using magnetic resonance to scan the human body to detect cancer. On September 17, 1969, Dr. Damadian sent a letter to Dr. George Mirick ...